Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2020 | 02-2020 | 11-2019 | 08-2019 | 05-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,279 | 1,983 | 3,375 | 4,424 | 286 |
| Receivables | N/A | 30 | 46 | N/A | 7 |
| Other current assets | 99 | 2 | 2 | 0 | 833 |
| TOTAL | $1,453 | $2,111 | $3,508 | $4,443 | $1,152 |
| Non-Current Assets | |||||
| PPE Net | 2 | 2 | 1 | 1 | 1 |
| Intangibles | 2,039 | 2,039 | 2,039 | 2,039 | 0 |
| TOTAL | $2,041 | $2,041 | $2,040 | $2,040 | $1 |
| Total Assets | $3,494 | $4,152 | $5,548 | $6,483 | $1,153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 268 | 444 | 585 | 992 | 919 |
| Other current liabilities | N/A | N/A | N/A | 30 | 100 |
| TOTAL | $269 | $444 | $585 | $1,022 | $1,019 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $269 | $444 | $585 | $1,022 | $1,019 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50 | 38 | 38 | N/A | 38 |
| Common Shares | 4 | 3 | 3 | 3 | 2 |
| Retained earnings | -8,438 | -7,487 | -6,117 | -4,811 | -3,965 |
| Other shareholders' equity | 51 | 16 | 7 | -10 | -10 |
| TOTAL | $3,225 | $3,708 | $4,963 | $5,461 | $134 |
| Total Liabilities And Equity | $3,494 | $4,152 | $5,548 | $6,483 | $1,153 |